These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 8196357)
41. The Role of MET in Melanoma and Melanocytic Lesions. Zhou Y; Song KY; Giubellino A Am J Pathol; 2019 Nov; 189(11):2138-2148. PubMed ID: 31476283 [TBL] [Abstract][Full Text] [Related]
42. Autocrine growth stimulation as a potential source of asymmetry in melanocytic skin tumors. Smolle J; Hofmann-Wellenhof R Am J Dermatopathol; 1998 Aug; 20(4):352-6. PubMed ID: 9700372 [TBL] [Abstract][Full Text] [Related]
46. In this issue--oncogenes, tumor suppressor genes and melanocytic lesions. Udey MC; Hornyak TJ J Invest Dermatol; 2004 May; 122(5):VII-VIII. PubMed ID: 15140248 [No Abstract] [Full Text] [Related]
47. Loss of primary cilia in melanoma cells is likely independent of proliferation and cell cycle progression. Snedecor ER; Sung CC; Moncayo A; Rothstein BE; Mockler DC; Tonnesen MG; Jones EC; Fujita M; Clark RA; Shroyer KR; Chen J J Invest Dermatol; 2015 May; 135(5):1456-1458. PubMed ID: 25629424 [No Abstract] [Full Text] [Related]
48. New diagnostic method for lesions with transepidermal melanocytic migration. Scholz M; Buder S; Kerl K; Dummer R; Garbe C JAMA Dermatol; 2014 Jun; 150(6):654-6. PubMed ID: 24760281 [No Abstract] [Full Text] [Related]
49. Cytokines, growth factors and the loss of negative growth controls in the progression of human cutaneous malignant melanoma. Lu C; Kerbel RS Curr Opin Oncol; 1994 Mar; 6(2):212-20. PubMed ID: 8011699 [TBL] [Abstract][Full Text] [Related]
50. Molecular genetics of human malignant melanoma. Albino AP; Fountain JW Cancer Treat Res; 1993; 65():201-55. PubMed ID: 8104022 [TBL] [Abstract][Full Text] [Related]
51. Melanoma, vitiligo and topographic antigens. James DB Melanoma Res; 1993 Feb; 3(1):76-7. PubMed ID: 8471841 [No Abstract] [Full Text] [Related]
53. Nested melanoma. Kossard S Mod Pathol; 2013 Apr; 26(4):615-6. PubMed ID: 23542527 [No Abstract] [Full Text] [Related]
54. What we need to know about cancer genes. Leong AS; Leong FJ Diagn Cytopathol; 1998 Jan; 18(1):33-40. PubMed ID: 9451556 [No Abstract] [Full Text] [Related]
55. Minimally invasive microbiopsy for genetic profiling of melanocytic lesions: A case series. Jain M; Autuori I; Everett N; Harris U; Yamada M; Prow T; Busam K; Marchetti MA; Halpern AC; Orlow I J Am Acad Dermatol; 2022 Oct; 87(4):903-904. PubMed ID: 34922919 [TBL] [Abstract][Full Text] [Related]
56. Morphology of melanocytic lesions in situ. Balois T; Ben Amar M Sci Rep; 2014 Jan; 4():3622. PubMed ID: 24406374 [TBL] [Abstract][Full Text] [Related]
58. Melanoma biology and new targeted therapy. Gray-Schopfer V; Wellbrock C; Marais R Nature; 2007 Feb; 445(7130):851-7. PubMed ID: 17314971 [TBL] [Abstract][Full Text] [Related]
59. Molecular pathology of melanoma. Newton Bishop JA Cancer Metastasis Rev; 1997 Jun; 16(1-2):141-54. PubMed ID: 9156284 [TBL] [Abstract][Full Text] [Related]
60. Dynamics of intercellular communication during melanoma development. Li G; Herlyn M Mol Med Today; 2000 Apr; 6(4):163-9. PubMed ID: 10740255 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]